Antibody response and protective capacity of plasmid vaccines expressing three different herpes simplex virus glycoproteins

Journal of Infectious Diseases

Volumn 178, Issue 3, 1998, Pages 611-617

  Nass, Petra H ^a,b   Elkins, Karen L ^a   Weir, Jerry P ^a  

^a CENTER FOR BIOLOGICS EVALUATION AND RESEARCH   (United States)

^b JOHNS HOPKINS BAYVIEW MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIGEN RECOGNITION; ARTICLE; HERPES SIMPLEX VIRUS 1; INFECTION PREVENTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

EID: 0031657180     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/515374     Document Type: Article

References (28)

1. Berman PW, Gregory T, Crase D, Lasky LA. Protection from genital herpes simplex virus type 2 infection by vaccination with cloned type 1 glycoprotein D. Science 1985;227:1490-2.
2. Stanberry LR, Bernstein DI, Burke RL, Pachl C, Myers MG. Vaccination with recombinant herpes simplex virus glycoproteins: protection against initial and recurrent genital herpes. J Infect Dis 1987;155:914-20.
3. Straus SE, Savarese B, Tigges M, et al. Induction and enhancement of immune responses to herpes simplex virus type 2 in humans by use of a recombinant glycoprotein D vaccine. J Infect Dis 1993;167:1045-52.
4. Straus SE, Corey L, Burke RL, et al. Placebo-controlled trial of vaccination with recombinant glycoprotein D of herpes simplex virus type 2 for immunotherapy of genital herpes. Lancet 1994;343:1460-3.
5. Donnelly JJ, Ulmer JB, Shiver JW, Liu MA. DNA vaccines. Annu Rev Immunol 1997;15:617-48.
6. Chattergoon M, Boyer J, Weiner DB. Genetic immunization: a new era in vaccines and immune therapeutics. FASEB J 1997;11:753-63.
7. Barry MA, Lai WC, Johnston SA. Protection against mycoplasma infection using expression-library immunization. Nature 1995;377:632-5.
8. Manickan E, Rouse RJD, Yu Z, Wire WS, Rouse BT. Genetic immunization against herpes simplex virus. J Immunol 1995;155:259-65.
9. Manickan E, Yu Z, Rouse RJD, Wire WS, Rouse BT. Induction of protective immunity against herpes simplex virus with DNA encoding the immediate-early protein ICP27. Viral Immunol 1995;8:53-61.
10. Ghiasi H, Cai S, Slanina S, Nesbum AB, Wechsler SL. Vaccination of mice with herpes simplex virus type l glycoprotein D DNA produces low levels of protection against lethal HSV-2 challenge. Antiviral Res 1995;28:147-57.
11. McClements WL, Armstrong ME, Keys RD, Liu MA. Immunization with DNA vaccines encoding glycoprotein D or glycoprotein B, alone or in combination, induces protective immunity in animal models of herpes simplex virus-2 disease. Proc Natl Acad Sci USA 1996;93:11414-20.
12. Kriesel JD, Spruance SL, Daynes RA, Araneo B A. Nucleic acid vaccine encoding gD2 protects mice from herpes simplex virus type 2 disease. J Infect Dis 1996;173:536-41.
13. Bourne N, Stanberry LR, Bernstein DI, Lew D. DNA immunization against experimental genital herpes simplex-virus infection. J Infect Dis 1996; 173:800-7.
14. Ausubel FM, Brent R, Kingston RE, et al, eds. Current protocols in molecular biology. New York, NY: Greene and Wiley, 1987.
15. Weir JP, Bennett M, Alen EM, Elkins KL, Martin S, Rouse BT. Recombinant vaccinia virus expressing the herpes simplex virus type 1 glycoprotein C protects mice against herpes simplex virus challenge. J Gen Virol 1989;70:2587-94.
16. Lennette EH. General principles underlying laboratory diagnosis of virus and rickettsial infections. In: Lennette EH, Schmidt NJ, eds. Diagnostic procedures of virus and rickettsial disease. New York, NY: American Public Health Association, 1964:45.
17. Pachl C, Burke RL, Stuve LL, et al. Expression of cell associated and secreted forms of herpes simplex virus type 1 glycoprotein gB in mammalian cells. J Virol 1987:61:315-25.
18. Fynan EF, Webster RG, Fuller DH, Haynes JR, Santoro JC, Robinson HL. DNA vaccines: protective immunizations by parenteral, mucosal, and genegun inoculations. Proc Natl Acad Sci USA 1993;90:11478-82.
19. Wang B, Ugen KE, Srikantan V, et al. Gene inoculation generates immune responses against human immunodeficiency virus type 1. Proc Natl Acad Sci USA 1993;90:4156-60.
20. Sato Y, Roman M, Tighe H, et al. Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science 1996;273:352-4.
21. Raz E, Carson DA, Parker SE, et al. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci USA 1994;91:9519-23.
22. Pertmer TM, Roberts TR, Haynes JR. Influenza virus nucleoprotein-specific immunoglobulin G subclass and cytokine responses elicited by DNA vaccination are dependent on the route of vector DNA delivery. J Virol 1996;70:6119-25.
23. Spear PG. Entry of alphaherpesviruses into cells. Semin Virol 1993;4: 167-80.
24. Friedman HM, Cohen GH, Eisenberg RJ, Seidel CA, Cines DB. Glycoprotein C of herpes simplex virus 1 acts as a receptor for the C3b complement component on infected cells. Nature 1984;309:633-5.
25. Dingwell KS, Doering LC, Johnson DC. Glycoprotein E and I facilitate neuron-to-neuron spread of herpes simplex virus. J Virol 1995;69: 7087-98.
26. Johnson DC, Frame MC, Ligas MW, Cross AM, Stow ND. Herpes simplex virus immunoglobulin G Fc receptor activity depends on a complex of two viral glycoproteins, gE and gI. J Virol 1988;62:1347-54.
27. Ghiasi H, Kaiwar R, Nesburn AB, Slanina S, Wechsler SL. Expression of seven herpes simplex virus type 1 glycoproteins (gB, gC, gE, gG, gH, and gI): comparative protection against lethal challenge in mice. J Virol 1994;68:2118-26.
28. Blacklaws BA, Krishna S, Minson AC, Nash AA. Immunogenicity of herpes simplex virus type 1 glycoproteins expressed in vaccinia virus recombinants. Virology 1990;177:727-36.